Capitalizing a cure : how finance controls the price and value of medicines /

Show other versions (2)

"Capitalizing a Cure takes us into the struggle over accessing a medical breakthrough to investigate the power of finance over business, biomedicine, and public health. When sofosbuvir-based medicines launched in 2013, they promised a cure for millions of patients worldwide with hepatitis C. Bu...

Full description

Bibliographic Details
Call Number:Libro Electrónico
Main Author: Roy, Victor, 1986- (Author)
Format: Electronic eBook
Language:Inglés
Published: Oakland, California : University of California Press, [2023]
Subjects:
Gilead Sciences (Firm)
Drugs > Prices > United States.
Pharmaceutical industry > Economic aspects > United States.
Drug development > Economic aspects > United States.
Sofosbuvir > Prices > United States.
Hepatitis C > Treatment > Prices > United States.
Médicaments > Prix > États-Unis.
Industrie pharmaceutique > Aspect économique > États-Unis.
Médicaments > Développement > Aspect économique > États-Unis.
Hépatite C > Traitement > Prix > États-Unis.
Drugs > Prices
Pharmaceutical industry > Economic aspects
United States
Online Access:Texto completo

Internet

Texto completo

Error inesperado del formato de respuesta.
Holdings details from

Similar Items